Stage III Renal Pelvis Cancer AJCC v8
Drug | Drug Name | Drug Description |
---|
Drug | Drug Name | Target | Type |
---|
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB08875 | Cabozantinib | 1 | Active Not Recruiting | 1 |
DB06186 | Ipilimumab | 1 | Active Not Recruiting | 1 |
DB09035 | Nivolumab | 1 | Active Not Recruiting | 1 |
DB11595 | Atezolizumab | 2 | Active Not Recruiting | 2 |
DB11945 | Avelumab | 2 | Completed | 1 |
DB14547 | Chloride ion | 2 | Completed | 1 |
DB00515 | Cisplatin | 2 | Completed | 1 |
DB08871 | Eribulin | 2 | Active Not Recruiting | 1 |
DB00530 | Erlotinib | 2 | Completed | 1 |
DB00544 | Fluorouracil | 2 | Completed | 1 |
DB00441 | Gemcitabine | 2 | Terminated | 1 |
DB11997 | Interleukin-7 | 2 | Active Not Recruiting | 1 |
DB06186 | Ipilimumab | 2 | Active Not Recruiting | 1 |
DB00305 | Mitomycin | 2 | Completed | 1 |
DB09035 | Nivolumab | 2 | Active Not Recruiting | 1 |
DB09035 | Nivolumab | 2 | Recruiting | 1 |
DB12257 | Platinum | 2 | Completed | 1 |
DB14851 | Relatlimab | 2 | Recruiting | 1 |
DB06273 | Tocilizumab | 2 | Active Not Recruiting | 1 |
DB11945 | Avelumab | 3 | Active Not Recruiting | 1 |
DB08875 | Cabozantinib | 3 | Active Not Recruiting | 1 |